See also this year's filing and all EDGAR filings for this company.
PDF Report 0001528172_2021_Endonovo_Therapeutics_INC.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001528172, Endonovo Therapeutics INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 46,187 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 2,559,268 |
| 2 | PropertyPlantAndEquipmentNet | 1,580 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 16,825,821 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 155,000 |
| 7 | CostOfGoodsAndServicesSold | 69,698 |
| 8 | SellingGeneralAndAdministrativeExpense | 0 |
| 9 | ResearchAndDevelopmentExpense | 0 |
| 10 | remainder_Expenses | 3,076,585 |
| 11 | remainder_Revenues | 193,508 |
| 12 | remainder_NetIncome | -13,496,136 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 2,607,035 |
| 1 | Liabilities | 16,980,821 |
| 2 | Expenses | 3,146,283 |
| 3 | Revenues | 193,508 |
| 4 | StockholdersEquity | -14,373,786 |
| 5 | NetIncome | -16,448,911 |
| 6 | ComprehensiveNetIncome | -16,448,911 |
| 7 | BaseVar | 18,211,892 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -4.88 |
| 9 | EconomicCapitalRatio | 0.210 |